SCHEMBL529005

SCHEMBL529005

O=C[C@H](OC(=O)CNC(=O)c1ccc(O)cc1)[C@@H](OC(=O)CNC(=O)c1cccc(O)c1)[C@H](O)[C@H](O)CO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.35
GLA P06280 1/20 0.34
EGLN2 Q96KS0 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
PTPRC P08575 2/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
ESRRG P62508 1/20 0.32
KMT2A Q03164 1/20 0.32
NAMPT P43490 1/20 0.31
KDM1A O60341 1/20 0.31
HDAC1 Q13547 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demannose SCHEMBL529006 0.78 KDM4E (0.40) KDM4EALDH1A1MAPK1EGLN2PTPRC
SCHEMBL3710132 0.68 SMN1; SMN2 (0.40) GLARAB9AKMT2A
SCHEMBL5371901 0.66 CA12 (0.45) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL13705851 0.64 KDM4E (0.61) KDM4EALDH1A1MAPK1EGLN2RAB9A
SCHEMBL1222443 0.64 SMN1; SMN2 (0.57) KDM4EALDH1A1MAPK1GLAEGLN2
SCHEMBL27113108 0.64 PTPRC (0.59) KDM4EALDH1A1MAPK1GLAEGLN2
SCHEMBL22215023 0.64 KMT2A (0.50) KDM4EALDH1A1MAPK1GLAEGLN2
Methyl Alcohol SCHEMBL6254729 0.63
SCHEMBL15142163 0.63 SERPINE1 (0.44) KDM4E
SCHEMBL5664340 0.63 SERPINE1 (0.44) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598873-A2 BIOMARKERS FOR PROSTATE CANCER AND METHODS USING THE SAME Metabolon, Inc. (US) 2013-06-05 EP disclosed
WO-2012015904-A2 BIOMARKERS FOR PROSTATE CANCER AND METHODS USING THE SAME METABOLON, INC. (US) 2012-02-02 WO disclosed